Boston Common Asset Management, LLC Danaher Corp Transaction History

Boston Common Asset Management, LLC

$3.84 Billion
Q3 2024

A detailed history of Boston Common Asset Management, LLC transactions in Danaher Corp stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 101,849 shares of DHR stock, worth $23.6 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

101,849

Previous 100,223 1.62%

Holding current value

$23.6 Million

Previous $25 Million 13.08%

% of portfolio

0.74%

Previous 0.64%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$239.25 - $280.76 $389,020 - $456,515	1,626 Added 1.62%	101,849 $28.3 Million
Q2 2024 Jul 08, 2024	BUY	$235.51 - $267.98 $1.31 Million - $1.49 Million	5,574 Added 5.89%	100,223 $25 Million
Q1 2024 Apr 11, 2024	BUY	$224.58 - $256.19 $16.6 Million - $18.9 Million	73,931 Added 356.84%	94,649 $23.6 Million
Q4 2023 Jan 09, 2024	SELL	$185.1 - $233.13 $136,048 - $171,350	-735 Reduced 3.43%	20,718 $4.79 Million
Q3 2023 Oct 11, 2023	SELL	$233.08 - $265.59 $34,728 - $39,572	-149 Reduced 0.69%	21,453 $5.32 Million
Q2 2023 Jul 24, 2023	SELL	$224.99 - $256.14 $2.3 Million - $2.62 Million	-10,211 Reduced 32.1%	21,602 $5.18 Million
Q1 2023 May 17, 2023	SELL	$239.75 - $277.0 $562,213 - $649,565	-2,345 Reduced 6.87%	31,813 $8.02 Million
Q4 2022 Jan 26, 2023	SELL	$241.42 - $282.29 $11,829 - $13,832	-49 Reduced 0.14%	34,158 $9.07 Million
Q3 2022 Oct 20, 2022	BUY	$247.06 - $1507.4 $1.59 Million - $9.73 Million	6,452 Added 23.25%	34,207 $8.84 Million
Q2 2022 Aug 10, 2022	SELL	$237.11 - $299.66 $36,040 - $45,548	-152 Reduced 0.54%	27,755 $7.04 Million
Q1 2022 May 16, 2022	BUY	$257.27 - $315.76 $49,138 - $60,310	191 Added 0.69%	27,907 $8.19 Million
Q4 2021 Jan 31, 2022	BUY	$292.08 - $329.01 $373,278 - $420,474	1,278 Added 4.83%	27,716 $9.12 Million
Q3 2021 Nov 12, 2021	SELL	$272.21 - $332.43 $200,346 - $244,668	-736 Reduced 2.71%	26,438 $8.05 Million
Q2 2021 Aug 19, 2021	SELL	$225.08 - $271.69 $47,942 - $57,869	-213 Reduced 0.78%	27,174 $7.29 Million
Q1 2021 May 14, 2021	SELL	$212.38 - $245.9 $1.19 Million - $1.38 Million	-5,620 Reduced 17.03%	27,387 $6.16 Million
Q4 2020 Feb 05, 2021	SELL	$212.5 - $245.46 $3.16 Million - $3.65 Million	-14,854 Reduced 31.04%	33,007 $7.33 Million
Q3 2020 Nov 10, 2020	SELL	$177.16 - $215.33 $1.47 Million - $1.79 Million	-8,305 Reduced 14.79%	47,861 $10.3 Million
Q2 2020 Aug 10, 2020	BUY	$128.7 - $176.83 $694,851 - $954,705	5,399 Added 10.63%	56,166 $9.93 Million
Q1 2020 May 08, 2020	SELL	$121.39 - $169.05 $223,478 - $311,221	-1,841 Reduced 3.5%	50,767 $7.03 Million
Q4 2019 Jan 28, 2020	SELL	$133.47 - $153.48 $2.07 Million - $2.37 Million	-15,474 Reduced 22.73%	52,608 $8.07 Million
Q3 2019 Nov 07, 2019	SELL	$135.4 - $146.47 $737,930 - $798,261	-5,450 Reduced 7.41%	68,082 $9.83 Million
Q2 2019 Jul 26, 2019	BUY	$124.88 - $143.73 $187,569 - $215,882	1,502 Added 2.09%	73,532 $10.5 Million
Q1 2019 May 03, 2019	SELL	$97.62 - $132.29 $238,485 - $323,184	-2,443 Reduced 3.28%	72,030 $9.51 Million
Q4 2018 Jan 25, 2019	BUY	$94.85 - $109.54 $250,878 - $289,733	2,645 Added 3.68%	74,473 $7.68 Million
Q3 2018 Nov 01, 2018	SELL	$98.13 - $108.9 $432,262 - $479,704	-4,405 Reduced 5.78%	71,828 $7.81 Million
Q2 2018 Aug 06, 2018	BUY	$96.1 - $103.24 $113,878 - $122,339	1,185 Added 1.58%	76,233 $7.52 Million
Q1 2018 Apr 26, 2018	BUY	$92.16 - $103.8 $389,007 - $438,139	4,221 Added 5.96%	75,048 $7.35 Million
Q4 2017 Feb 07, 2018	BUY	$85.26 - $94.62 $246,145 - $273,167	2,887 Added 4.25%	70,827 $6.57 Million
Q3 2017 Nov 13, 2017	BUY	$79.29 - $88.45 $227,562 - $253,851	2,870 Added 4.41%	67,940 $5.83 Million
Q2 2017 Aug 14, 2017	BUY	N/A	65,070	65,070 $5.49 Million

Others Institutions Holding DHR

# of Institutions

2,511

Shares Held

540M

Call Options Held

7.07M

Put Options Held

4.55M

View Full List

About DANAHER CORP

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $168B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

More about DHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.

Account

Boston Common Asset Management, LLC Danaher Corp Transaction History